BAI
BenevolentAI is a biopharma AI company focused on applying advanced artificial intelligence to accelerate drug discovery and life sciences research. The company combines science and technology, leveraging a knowledge graph and proprietary ontologies to support scientists and executives in making data-driven, high-confidence R&D decisions. It positions itself as a pioneer in life science intelligence with global operations in biopharma innovation and drug discovery, including partnerships and activities in Luxembourg and beyond.
No recent deals for this company.